ACH · Accendra Health Inc/Va/
$0.95
-0.15 (-13.55%)
At close · Aug 14
Market Cap
$78.44M
Shares
76.90M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Edward A. Pesicka | President & Chief Executive Officer | $10,737,905 |
| Andrew Long | Executive Vice President, Chief Executive Officer, Products & Healthcare Services | $4,026,436 |
| Perry A. Bernocchi | Executive Vice President, Chief Executive Officer, Patient Direct | $3,652,733 |
| Alexander Bruni | Former Executive Vice President & Chief Financial Officer | $2,928,586 |
| Jonathan A. Leon | Executive Vice President & Chief Financial Officer | $2,290,912 |
| Heath H. Galloway | Executive Vice President, General Counsel & Corporate Secretary | $2,171,222 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Edward A. Pesicka | President & Chief Executive Officer | $8,389,910 |
| Andrew Long | Executive Vice President, Chief Executive Officer, Products & Healthcare Services | $4,724,545 |
| Perry A. Bernocchi | Executive Vice President, Chief Executive Officer, Patient Direct | $3,190,882 |
| Daniel J. Starck | Executive Vice President, Business Excellence Former, Executive Vice President, President – Patient Direct & CEO of Apria | $3,153,991 |
| Alexander Bruni | Former Executive Vice President & Chief Financial Officer | $2,027,254 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Edward A. Pesicka | President & Chief Executive Officer | $6,245,259 |
| Daniel J. Starck | Executive Vice President, Business Excellence Former, Executive Vice President, President – Patient Direct & CEO of Apria | $5,124,951 |
| Andrew Long | Executive Vice President, Chief Executive Officer, Products & Healthcare Services | $3,064,459 |
| Jeffrey T. Jochims | Former Executive Vice President, Chief Operating Officer & President, Products & Healthcare Services | $2,865,197 |
| Tammy L. Gomez | Executive Vice President & Chief Human Resources Officer | $2,834,407 |
| Nicholas J. Pace | Executive Vice President, General Counsel & Corporate Secretary | $1,929,464 |
| Alexander Bruni | Former Executive Vice President & Chief Financial Officer | $875,361 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Edward A. Pesicka | President & Chief Executive Officer | $7,680,578 |
| Christopher Lowery | President Global Products | $3,624,951 |
| Jeffrey T. Jochims | Former Executive Vice President, Chief Operating Officer & President, Products & Healthcare Services | $3,577,675 |
| Andrew Long | Executive Vice President, Chief Executive Officer, Products & Healthcare Services | $3,565,487 |
| Mark P. Zacur | Former Executive Vice President, Chief Commercial Officer | $3,545,120 |
| Nicholas J. Pace | Executive Vice President, General Counsel & Corporate Secretary | $2,577,109 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Edward A. Pesicka | President & Chief Executive Officer | $7,628,179 |
| Andrew Long | Executive Vice President, Chief Executive Officer, Products & Healthcare Services, Former Executive Vice President & Chief Financial Officer | $2,339,266 |
| Christopher Lowery | President Global Products | $2,261,130 |
| Jeffrey T. Jochims | Former Executive Vice President, Chief Operating Officer & President, Products & Healthcare Services | $2,232,007 |
| Nicholas J. Pace | Executive Vice President, General Counsel & Corporate Secretary | $1,600,124 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Edward A. Pesicka | President & Chief Executive Officer | $5,570,489 |
| Christopher Lowery | President Global Products | $1,837,120 |
| Nicholas J. Pace | Executive Vice President, General Counsel & Corporate Secretary | $1,580,518 |
| Robert C. Sledd | Former President & Chief Executive Officer | $351,278 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Christopher Lowery | President, Global Products | $3,656,671 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Edward A. Pesicka | Director | Appointed | 2026-05-15 |
| Teresa L. Kline | Director | Appointed | 2026-05-15 |
| Stephen W. Klemash | Director | Appointed | 2026-05-15 |
| Kenneth Gardner-Smith | Director | Appointed | 2026-05-15 |
| Gwendolyn M. Bingham | Director | Appointed | 2026-05-15 |
| Mark A. Beck | Director | Appointed | 2026-05-15 |
| Perry A. Bernocchi | Executive Vice President, Chief Operating Officer | Appointed | 2025-12-08 |
| Snehashish Sarkar | Executive Vice President and Chief Information Officer | Resigned | 2025-09-19 |
| Jonathan A. Leon | Executive Vice President, Chief Financial Officer | Appointed | 2024-09-23 |
| Alexander J. Bruni | Executive Vice President & Chief Financial Officer | Resigned | 2024-06-24 |
| Jonathan A. Leon | Interim Chief Financial Officer | Appointed | 2024-06-24 |
| Jennifer Stone | Executive Vice President & Chief Human Resources Officer | Appointed | 2024-05-24 |
| Snehashish Sarkar | Executive Vice President & Chief Information Officer | Appointed | 2024-05-09 |
| Dan J. Starck | Executive Vice President, Business Excellence | Retired | 2024-04-22 |
| Tammy L. Gomez | Executive Vice President and Chief Human Resources Officer | Resigned | 2023-12-15 |
| Carissa L. Rollins | director | Appointed | 2023-05-12 |
| Edward A. Pesicka | director | Appointed | 2023-05-12 |
| Stephen W. Klemash | director | Appointed | 2023-05-12 |
| Teresa L. Kline | director | Appointed | 2023-05-12 |
| Robert J. Henkel | director | Appointed | 2023-05-12 |
| Rita F. Johnson-Mills | director | Appointed | 2023-05-12 |
| Gwendolyn M. Bingham | director | Appointed | 2023-05-12 |
| Kenneth Gardner-Smith | director | Appointed | 2023-05-12 |
| Mark A. Beck | director | Appointed | 2023-05-12 |
| Heath H. Galloway | Executive Vice President, General Counsel and Corporate Secretary | Appointed | 2023-04-19 |
Key facts
CIK
75252
CUSIP
690732102
13F (30d)
133 filings
132 filers
Visit website
Investor relations